Key elements in the quality assessment of a type 3 medication review Tekijä Anneleen Robberechts, Anneleen Robberechts, Anneleen Robberechts, Melissa Michielsen, Stephane Steurbaut, Stephane Steurbaut, Guido R. Y. De Meyer, Hans De Loof

Hae kokoteksti

Use of the BRANT-MERQS scoring table for the quality assessment of type 3 medication review in patients with rheumatoid arthritis and those with type 2 diabetes mellitus Tekijä Anneleen Robberechts, Anneleen Robberechts, Anneleen Robberechts, Kaat Stas, Margot Puttemans, Laura Poppe, Stephane Steurbaut, Stephane Steurbaut, Guido R. Y. De Meyer, Guido R. Y. De Meyer, Hans De Loof, Hans De Loof

Hae kokoteksti

Medication Review: What’s in a Name and What Is It about? Tekijä Anneleen Robberechts, Maja Brumer, Victoria Garcia-Cardenas, Niurka M. Dupotey, Stephane Steurbaut, Guido R. Y. De Meyer, Hans De Loof

Hae kokoteksti